Register

I agree with the Privacy Policy

In The News

mHealth Looks to Solve the Diabetes Care Management Conundrum

September 29, 2017

remote health monitoring

connected health devices

Earlier this year, a report from digital health analyst Parks Associates found that 27 percent of people with a chronic condition want a mobile health device that tracks their health, but a significant percentage of those now using such devices say they’re too complicated or don’t work well.

"Nearly one-half of type I diabetics and one-third of type II diabetics are interested in health monitoring devices such as glucometers, but a steep learning curve and difficult or counterintuitive directions could inhibit their usage of these devices and also prevent them from buying other connected health devices," Harry Wang, the group’s senior director of research, said in a press release accompanying the report. "Device and application manufacturers would benefit from improving the ease-of-use of these devices."

From the article "mHealth Looks to Solve the Diabetes Care Management Conundrum" by Eric Wicklund.

Previously In The News

Apple Needs Netflix and HBO More Than They Need It

According to a survey from Parks Associates, 36% of households subscribe to two or more streaming video services. If Apple provides a convenient way for subscribers to see all of their paid content in...

AT&T Deal: Merger For New Media Era Or A Bad Remake?

Pay-TV operators are seeing a "slow erosion of the core business," analyst Brett Sappington at Parks Associates said. "After years of attempts to be more than just a 'dumb pipe,' pay-TV operators h...

Google's Next Chromecast Could Look More Like a Roku Box

Things have changed. Parks Associates analysis in 2014 found that Chromecast had replaced Apple TV in second place behind Roku. Its market share was 20%. In 2019, though, Parks Associates found that o...

The Simple Reason Why I Won't Buy Roku Inc.

Roku (NASDAQ:ROKU) went public on Sep. 28, its stock surging nearly 70% from its IPO price of $14 per share. The stock hit almost $30 the following day, but subsequently pulled back to the low $20s....

‹
1
2
...
356
357
358
359
360
361
362
...
751
752
›